View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOD/DODOASHA | RIN: 0720-AB31 | Publication ID: Fall 2010 |
Title: TRICARE; Coverage of National Cancer Institute (NCI) Sponsored Phase I Studies | |
Abstract: This rule adds coverage of National Cancer Institute (NCI) sponsored Phase I studies for certain beneficiaries. The NCI sponsored clinical treatment trials are conducted in a series of steps called phases. Phase I trials are the first studies conducted in people. They evaluate how a new drug should be given (by mouth, injected into the blood, or injected into the muscle), how often, and what dose is safe. | |
Agency: Department of Defense(DOD) | Priority: Substantive, Nonsignificant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 32 CFR 199 | |
Legal Authority: 10 USC ch 55 5 USC 301 |
Legal Deadline:
None |
||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: John Kugler Department of Defense Office of Assistant Secretary for Health Affairs 1200 Defense Pentagon, Washington, DC 20301-1200 Phone:703 681-0064 Email: john.kugler@tma.osd.mil |